Skip to main content
Clinical Trials/JPRN-UMIN000007653
JPRN-UMIN000007653
Completed
未知

Clinical observation study of 5-year survivals in patients with newly diagnosed acute lymphoblastic leukemia (ALL) in Japan Adult Leukemia Study Group (JALSG). (JALSG-ALL-CS-12) - JALSG ALL clinical observation study 12 (JALSG-ALL-CS-12)

Japan Agency for Medical Research and Development Japan Adult Leukemia Study Group0 sites733 target enrollmentApril 3, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Acute lymphoblastic leukemia
Sponsor
Japan Agency for Medical Research and Development Japan Adult Leukemia Study Group
Enrollment
733
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 3, 2012
End Date
March 1, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Japan Agency for Medical Research and Development Japan Adult Leukemia Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Past history of chemotherapy or stem cell transplantation in the treatment of A

Outcomes

Primary Outcomes

Not specified

Similar Trials